A Pilot Study to Assess Safety and Efficacy of SIR1-365 in Patients With Severe COVID-19

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 18, 2020

Primary Completion Date

November 27, 2021

Study Completion Date

November 27, 2021

Conditions

Corona Virus Infection

Interventions

DRUG

SIR1-365

Route of administration: oral

DRUG

Matching Placebo

Route of administration: oral

Trial Locations (9)

Hospital Civil Fray Antonio Alcalde, Guadalajara

Media Sur - Medica Sur Tlalpan, Tlalpan

Triple O Research Institute, West Palm Beach

Baptist Medical Center, Jackson

OSF St. Francis Medical Center, Peoria

"Hospital Universitario Dr. José Eleuterio González", Monterrey

Dow University Hospital, Ojha Karachi, Karachi

Sindh Infectious Disease Hospital, Karachi

Aga Khan University Hospital, Karachi

All Listed Sponsors

lead

Sironax USA, Inc.

INDUSTRY

NCT04622332 - A Pilot Study to Assess Safety and Efficacy of SIR1-365 in Patients With Severe COVID-19 | Biotech Hunter | Biotech Hunter